Healthpeak Properties, Inc. (DOC) earnings on August 4, 2026

After the market closes Q2 2026

More Healthpeak Properties, Inc. earnings

Prior outlook: Pessimistic Outcome: Missed

Healthpeak Properties' stock rose 1.25% after its earnings report, despite a prior negative outlook. The company's quarterly numbers beat estimates and it raised its future outlook.

DOC price around the earnings

21.79

Change: +0.8%

2026-08-05, 20:00 UTC

Start of the measured window End of the measured window
21.57 21.94 22.30 22.67 21.62
Price series around the eventClosing price per minute from before the event to the end of the measured window.No trading (market closed)No trading (market closed)
August 4, 2026 August 5, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • No trading (market closed)
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Pessimistic Outcome: Missed

Thesis published
Results released

Negative trend strength and trajectory collapse, but strategic JV with Brookfield provides fundamental support.

Context analyzed before publication

Trend
Significant cool-off and negative trend strength into earnings, with conservative analyst targets.

Analysts

Evidence

Analyst consensus
Buy
Consensus average (1-5)
2.41
Analysts covering the stock
19
Average price target
22.39
Lowest price target
17
Highest price target
29
Upside to price target
3.8%
Quarterly earnings growth
352.1%
Revenue growth
7.1%
Forward EPS
-0.15
Trailing EPS
0.32
Analyst moves in the last 60 days
7
  • Strong buy: 3
  • Buy: 5
  • Hold: 14
  • Sell: 0
  • Strong sell: 0
Strong buy
3
Buy
5
Hold
14
Sell
0
Strong sell
0
  • July 15, 2026 · Wells Fargo: Maintains rating (Equal-Weight → Equal-Weight)
  • July 8, 2026 · UBS: Maintains rating (Neutral → Neutral)
  • July 7, 2026 · Barclays: Initiates coverage (Overweight → Equal-Weight)
  • July 6, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
  • June 24, 2026 · JP Morgan: Maintains rating (Neutral → Neutral)
  • June 15, 2026 · BMO Capital: Maintains rating (Outperform → Outperform)
  • June 11, 2026 · Morgan Stanley: Downgrades rating (Overweight → Equal-Weight)

Technicals

Evidence

Price when the context was analyzed
21.65
Average true range (ATR)
2%
Distance to 52-week high
-5.4%
14-day change (14d)
-2.9%
30-day change (32d)
-1.0%
30-day relative strength
-2.7%
SPY change (32d)
+1.7%
Nearest support
21.56
Distance to nearest support
0.4%
Nearest resistance
21.66
Distance to nearest resistance
0.1%
Volume accumulation ratio (14d / 46d)
0.91
  • Major: 21.56 (0.4% away, 0.21 ATR, 24 touches)
  • Minor: 21.38 (1.3% away, 0.63 ATR, 7 touches)
  • Major: 21.27 (1.8% away, 0.88 ATR, 27 touches)
  • Major: 21.66 (0.1% away, 0.02 ATR, 30 touches)
  • Major: 21.91 (1.2% away, 0.6 ATR, 35 touches)
  • Major: 22.11 (2.1% away, 1.05 ATR, 27 touches)

Trends

Evidence

Average earnings surprise
+7.9%
  • May 5, 2026: actual EPS 0.28 vs estimate 0.06 (surprise +363.1%)
  • February 2, 2026: actual EPS 0.1 vs estimate 0.06 (surprise +59.3%)
  • October 23, 2025: actual EPS -0.18 vs estimate 0.06 (surprise -403.2%)
  • July 24, 2025: actual EPS 0.06 vs estimate 0.06 (surprise +12.2%)

Expected move

Implied move
+1.7%
Source
Options chain

Reactions over its last 20 earnings

Median move
2.5%
75th percentile move
3.5%
90th percentile move
5.6%
Up / down moves
7 / 13
Average up move
+4.8%
Average down move
-2.6%

Monitoring and close

What Healthpeak Properties, Inc. reported

Status
Finished
Actual EPS0.46
EPS estimate0.44
EPS surprise+4.5%
Revenue$772 million
Revenue estimate$720 million
Revenue surprise+7.2%

Healthpeak Properties beat Q2 expectations with FFO of $0.46 per share and revenue of $771.6M. The company raised its FY2026 FFO guidance, reflecting optimism.

Sources (4)

Pre-market second reading after the results

Verdict
Beat expectations

Heading into the open, the results beat expectations on both earnings and revenue, and the price is indicating +2.0% pre-market, a move in line with the stock's usual reaction (about 2%). The figures don't confirm the prior scenario: the comparable cases aren't consistent enough.

How the stock reacted

Outcome
Missed
Consolidated
+1.3%
Max favorable move (MFE)
0.2%
Max adverse move (MAE)
3.8%